Bay Street News, 2024

MONTRÉAL, April 22, 2024 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has redeemed US$200 million principal amount […]

DAYTONA BEACH, Fla., April 22, 2024 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE:BRO) (the “Company”) announced its unaudited financial […]

KNOXVILLE, Tenn., April 22, 2024 (GLOBE NEWSWIRE) — SmartFinancial, Inc. (“SmartFinancial” or the “Company”; NYSE: SMBK), today announced net income […]

CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, […]

DURHAM, N.C., April 22, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing […]

VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”) will report Q1 2024 results […]

VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) — Lithium Americas (Argentina) Corp. (TSX: LAAC) (NYSE: LAAC) (“Lithium Argentina” or […]

HAMILTON, N.J., April 22, 2024 (GLOBE NEWSWIRE) — First Bank (Nasdaq Global Market: FRBA) (the Bank) today announced results for […]

– El principal producto candidato, el VCN-01, en combinación con irinotecán liposomal, demostró mayores efectos antitumorales en un xenoinjerto pancreático […]

– Lead product candidate, VCN-01 in combination with liposomal irinotecan demonstrated enhanced anti-tumor effects in a human pancreatic mouse xenograft– […]